NEW YORK (GenomeWeb) – Genomic data firm PierianDx today announced it is exclusively licensing a proprietary genetic testing tool and processes from Washington University in St. Louis.

PierianDx will offer the tool, called the Clinical Genomicist Workstation, to other clinical labs "giving them an end-to-end solution for managing clinical next-generation sequencing processes." CGW is a software platform for NGS clinical tests that manages data and workflow, the St. Louis-based company said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.